Drug Updates

Recent Clinical Updates

Search and filter HCP Connect coverage by specialty, drug topic, reference, or clinical keyword.

Clinical Coverage

Search drug updates and clinical coverage.

8 loaded

WHO updates BRCA testing guidelines for breast and ovarian cancer: key recommendations for screening high-risk individuals.

FDA approves tirzepatide for weight management: dosing differences between Mounjaro and Zepbound.

CGRP inhibitors erenumab, fremanezumab, and galcanezumab reduce migraine frequency, offering new prevention options.

FDA approves Zycubo for Menkes disease: 78% reduction in mortality risk in pediatric patients.

Depemokimab approved for severe asthma: once-yearly injection for eosinophilic phenotype, enhancing treatment options.

FDA approves fitusiran for hemophilia: Antithrombin lowering therapy for patients 12 and older, enhancing treatment adherence.

FDA approves bimekizumab for moderate to severe plaque psoriasis: 75% PASI reduction in BE VIVID trial.

FDA approves dupilumab for allergic fungal rhinosinusitis: first indication for this condition, improving treatment options for patients.